In critically ill patients, serial measurements of blood lactate may indicate adequacy of therapy and predict development of multi-organ failure. We studied the accuracy, precision, and repeatability of the newly developed 800 Series Lactate Sensor (Ciba Corning Diagnostic Corp., Medfield, U.S.A.). Lactate levels determined with the sensor were compared with the standard laboratory method (Abbott TDX) in 75 paired arterial blood samples from 20 patients. Agreement between methods was determined and the mean coefficient of variation calculated for repeated measurements. The bias of the sensor , and the precision ±0.67. The coefficient of variation for repeated measurements was 1.95% with the sensor, and 11.5% with the TDX (P=0.007) . The new sensor offers a more reproducible, rapid method of measuring lactate, vital for serial measurements. The relatively wide limits of agreement between the methods reflect the greater variability of the TDX assay.
In critically ill patients, a lactate concentration less than 2 mmol/l is considered normal 1 . Increased lactate levels reflect an imbalance between lactate production and elimination, serve as a global marker of inadequate tissue oxygenation and reflect metabolic derangements in sepsis 2 . Measurement of lactate levels is of prognostic significance. Levels greater than 4 mmol/l have been shown to be associated with a poor outcome in patients with circulatory failure 3, 4 , myocardial infarction 5 , cardiac arrest 6 and in emergency department patients 7 . Blood lactate levels have been shown to be superior to oxygen-derived parameters in predicting outcome in septic shock 8 . However, there remains a considerable overlap in lactate values observed in survivors and non-survivors. Serial lactate measurements may be better than single measurements in predicting mortality or risk of development of multi-organ failure in circulatory shock [9] [10] [11] . Any method of lactate measure-ment should therefore not only accurately estimate circulating lactate levels, but must do so rapidly and in a reproducible manner, so as to detect changes in lactate levels during resuscitation for circulatory failure.
Conventional methods of measuring lactate are limited by a slow turnaround time. A new lactatespecific biosensor (800 Series Lactate Sensor, Ciba Corning Diagnostic Corp., Medfield, U.S.A.) has been developed. The Ciba Corning lactate sensor (CCLS) is a complete electrochemical cell that incorporates amperometric technology to measure lactate concentrations, and can be fitted on a blood-gas analyser. It may facilitate rapid, repeated measurements of whole blood lactate in the intensive care unit (ICU). It can thus dramatically reduce the turnaround time for lactate measurement. We conducted a prospective study to determine the accuracy, bias and precision of the new lactate sensor. We compared it with the conventional method used in the laboratory at our institute, and determined the repeatability of measurements obtained by both methods.
METHODS
Lactate levels were measured in the central biochemistry laboratory using the Abbott TDxFLx analyser (TDx Assays Manual, Abbott Laboratories, Abbott Park, IL, U.S.A., 1993). Blood was collected in a fluoride-containing tube to inhibit the glycolytic pathway in the red blood cells. The TDx analyser measures plasma lactate levels by an enzymelinked biochemical assay using Radiative Energy Attenuation technology (Abbott TDxFLx System Operations Manual, Abbott Laboratories, Abbott Park, IL, U.S.A., 1993). This method, referred to in this manuscript as the TDX method, was considered the standard against which the new lactate sensor was compared.
The lactate sensor was mounted on a Ciba Corning 865 blood gas analyser, which measures arterial blood gases and electrolytes including ionized calcium and glucose. It also incorporates a co-oximeter and calculates values for bicarbonate, base excess, total carbon dioxide and oxygenation parameters. A three-level quality control check for pH, lactate, blood gases and glucose was run each day prior to lactate analysis on the Ciba Corning 865 analyser using three external quality control solutions. Results were accepted if they lay within two standard deviations of mean values for the reference solutions. The analyser was located in the ICU.
All blood samples were obtained from patients who had arterial cannulae inserted previously for invasive blood pressure monitoring or for blood gas analyses. Seventy-five paired blood samples from 20 patients admitted to the intensive care unit were obtained as follows. On 12 occasions, 6 ml of blood drawn from each patient were divided into two sodium fluoride potassium oxalate tubes. Two ml of blood were also drawn immediately into a heparinized syringe (Acculyte, Ciba Corning, 7 units lithium-heparin). The sodium fluoride, potassium oxalate tubes were transported to the central biochemistry laboratory for lactate estimation by the TDX method. The blood sample in the heparinized syringe was analysed twice consecutively at room temperature by the lactate sensor mounted on the Ciba Corning 865 blood gas analyser in the ICU. On 17 occasions, 9 ml of blood drawn were divided into three sodium fluoride potassium oxalate tubes. These were transported to the central laboratory for lactate estimation by the TDX method. Blood then drawn into a heparinized syringe was analysed thrice consecutively at room temperature by the lactate sensor mounted on the Ciba Corning 865 blood gas analyser.
Correlation between values obtained by standard TDX method and by the new lactate sensor was measured. Agreement between the methods was determined using the Bland-Altman method 12 . To determine repeatability of measurement, the means and standard deviations (SD) of each set of repeated measurements were determined to calculate the coefficient of variation (CoV=SD/mean). The mean coefficients of variation by each method were compared using the two-tailed unpaired t test.
RESULTS
There was statistically significant correlation between lactate measurements obtained by the lactate sensor and by the TDX method ( Figure 1 Table 1 and Figure 2 . The mean CoV for repeated measurements with the CCLS was 1.95±1.1% (range 0.2% to 4.6%), while for the TDX method, the mean CoV was 11.5±17.7% (range 0 to 75.8%). This difference between the mean coefficients of variation was highly significant (P=0.007). Figure 3 shows the distribution of coefficients of variation with both methods.
DISCUSSION
Lactic acidosis is characterized by increases in blood lactate (>5 mmol/l) and a decrease in blood pH (<7.25) 2 . Hyperlactataemia (2-5 mmol/l) without acidosis may occur due to subtle imbalances between lactate production and lactate clearance in adequately perfused tissues, when buffering systems are able to mitigate any fall in pH 1 . Arterial pH, base deficit and the anion gap may remain in the normal range, and the anion gap has been shown to be unable to predict the presence of hyperlactataemia 13 . In such patients, it is essential to directly measure lactate levels, and any method of lactate measurement must measure lactate levels accurately in the range of 2 to 5 mmol/l.
Our study found only modest agreement between lactate levels measured by the new lactate sensor and the TDX method for lactate measurement, with a bias and precision of -0.38 and ±0.67 respectively. In addition, the limits of agreement and the confidence intervals were wide. The most striking finding was the high variability in lactate concentrations determined by the TDX method on the same blood sample, with the mean CoV for repeated measurements by the TDX being 11.5±17.7%. Hence, the relatively wide limits of agreement between the methods probably reflect the greater variability of the conventional TDX method. Aduen et al 7 compared a similar lactate electrode (SP7, NOVA) with the TDX and Kodak Ektachem 700XR, and in contrast to our findings, they found excellent agreement between lactate levels measured by the electrode and the TDX and Kodak Ektachem instruments, with a bias and precision of 0.19±0.47. and 0.09 ±0.34 respectively. They did not evaluate any of the methods for repeatability of measurements. The fact that the CCLS measures whole blood lactate while the TDX method analyses the plasma lactate concentration cannot account for the difference in measurements by the two methods in our study. Kruse and Carlson 14 as well as Aduen and others 7 have found excellent agreement and correlation between whole blood and plasma lactate values. Estimation of lactate levels by the TDX method requires that blood be first collected in a fluoride containing tube, and there is a possibility that inadequate mixing or improper collection may result in incomplete suppression of glycolysis in the erythrocytes during transport of samples to the laboratory and their storage. The plasma must then be separated in a centrifuge, and there may be variations in sample preparation and handling techniques by laboratory personnel. Thus, measurements by the TDX method are likely to be subject to preanalytical error. In addition, the time involved in sample transport, separation of plasma, performance of the assay and in reporting the result to the ICU results in a slow turnaround time. In contrast, with the lactate sensor all blood specimens were analysed immediately in the ICU. This eliminates the problem of lactate production by erythrocytes, as well as preanalytical error, because there is no processing of the collected blood. The lactate levels are available almost instantly (within two minutes). In addition, blood is conserved because only a small amount of blood (0.2 ml) is required, and several other parameters are obtained at the same time. Blood conservation may be an important consideration in infants and in unstable patients who require frequent blood sampling for laboratory tests 15 .
There has been considerable interest in measurement of serial lactate levels to assess adequacy of resuscitation from circulatory shock and to predict outcome in critically ill patients. Cowan and his colleagues reported that serial lactate measurements were better at predicting outcome than single measurements 9 , and Bakker et al 11 reported that only survivors from septic shock had a significant decrease in lactate during the first 24 hours. They also determined the "lactime" or the duration for which blood lactate was greater than 2 mmol/l, and found that duration of lactic acidosis was the best predictor of organ failure and survival. Vincent and others 10 found that in survivors of circulatory shock, lactate decreased by more than 5% in the first hour of fluid resuscitation, while patients who received similar therapy but did not experience a similar fall in lactate died. This degree of change cannot be reliably measured with the TDX method having a coefficient of variation of 11.5±17.7%. With the TDX method, the CoV exceeded 5% in three samples, 10% in six samples and 20% in four samples. On the other hand, the new CCLS measured lactate in a highly reproducible manner, with the mean CoV less than 2%; in no case was the CoV greater than 5%. Thus, the ability of the lactate sensor to provide rapid, reproducible estimates of whole blood lactate makes it a valuable tool for serial measurements. Changes in lactate observed during resuscitation can reliably be attributed to changes in the cardiopulmonary and metabolic status of the patient, rather than to laboratory variation or error.
In conclusion, the new lactate sensor (800 Series Lactate Sensor, Ciba Corning Diagnostic Corp., Medfield, U.S.A.) provides rapid, reproducible estimates of blood lactate levels, promotes blood conservation and can be reliable used for serial lactate measurements. Widespread adoption of this technology will also be dictated by considerations of cost and maintenance, which we did not study, and by the validity and utility of blood lactate as a measure of tissue dysoxia.
